Cargando…

Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection

Virus onslaughts continue to spread fear and cause rampage across the world every now and then. The twenty first century is yet again witnessing a gross global pandemic, Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Globally no vaccines o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krishna, Gayathri, Pillai, Vinod Soman, Veettil, Mohanan Valiya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Full Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834013/ https://www.ncbi.nlm.nih.gov/pubmed/32739174 http://dx.doi.org/10.1016/j.ejphar.2020.173450

Ejemplares similares

Upregulation of GLS1 Isoforms KGA and GAC Facilitates Mitochondrial Metabolism and Cell Proliferation in Epstein–Barr Virus Infected Cells
por: Krishna, Gayathri, et al.
Publicado: (2020)

Nipah Virus: Past Outbreaks and Future Containment
por: Soman Pillai, Vinod, et al.
Publicado: (2020)

Omicron SARS-CoV-2 antiviral on poly(lactic acid) with nanostructured copper coating: Wear effects
por: da Silva, Daniel J., et al.
Publicado: (2023)

In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2
por: Deshpande, Rujuta R., et al.
Publicado: (2020)

Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting
por: Sharifkashani, Sourena, et al.
Publicado: (2020)

Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation
por: Huang, Alice, et al.
Publicado: (2022)

Breakthrough SARS‐CoV‐2 infections in immune mediated disease patients undergoing B cell depleting therapy: A retrospective cohort analysis
por: Calabrese, Cassandra M, et al.
Publicado: (2022)

Functional and druggability analysis of the SARS-CoV-2 proteome
por: Cavasotto, Claudio N., et al.
Publicado: (2021)

Multipolymer microsphere delivery of SARS-CoV-2 antigens
por: Shahjin, Farah, et al.
Publicado: (2023)

Kaposi’s Sarcoma Associated Herpesvirus Entry into Target Cells
por: Chakraborty, Sayan, et al.
Publicado: (2012)

Architecture and self‐assembly of the SARS‐CoV‐2 nucleocapsid protein
por: Ye, Qiaozhen, et al.
Publicado: (2020)

Unclear but present danger: An asymptomatic SARS-CoV-2 carrier
por: Yu, Xuejing, et al.
Publicado: (2020)

Genomics functional analysis and drug screening of SARS-CoV-2
por: Chen, Long, et al.
Publicado: (2020)

Nonstructural protein 7 and 8 complexes of SARS‐CoV‐2
por: Zhang, Changhui, et al.
Publicado: (2021)

DNA-scaffolded multivalent vaccine against SARS-CoV-2
por: Chen, Fangfang, et al.
Publicado: (2023)

Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: Implications for treatment with IFN-β and IFN inducer
por: Shuai, Huiping, et al.
Publicado: (2020)

Mechanisms of instantaneous inactivation of SARS-CoV-2 by silicon nitride bioceramic
por: Pezzotti, G., et al.
Publicado: (2021)

Identification of potent small molecule inhibitors of SARS-CoV-2 entry
por: Mediouni, Sonia, et al.
Publicado: (2022)

SARS-CoV-2 infections in mRNA vaccinated individuals are biased for viruses encoding spike E484K and associated with reduced infectious virus loads that correlate with respiratory antiviral IgG levels
por: Mostafa, Heba H., et al.
Publicado: (2022)

Computational and theoretical exploration for clinical suitability of Remdesivir drug to SARS-CoV-2
por: Nayeem, Shaik Mahammad, et al.
Publicado: (2021)

In silico identification of strong binders of the SARS-CoV-2 receptor-binding domain
por: Behloul, Nouredine, et al.
Publicado: (2021)

Silencing SARS‐CoV Spike protein expression in cultured cells by RNA interference
por: Zhang, Yuanjiang, et al.
Publicado: (2004)

Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection
por: Liguori, Claudio, et al.
Publicado: (2020)

SARS-CoV2 neutralizing activity of ozone on porous and non-porous materials
por: Wolfgruber, Stella, et al.
Publicado: (2022)

Low rate of detection of SARS-CoV-2 RNA in deceased tissue donors
por: Greenwald, Melissa A., et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-1) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in pregnancy – An overview
por: Babarinsa, Isaac A., et al.
Publicado: (2021)

Magical bullets from an indigenous Indian medicinal plant Tinospora cordifolia: An in silico approach for the antidote of SARS-CoV-2()
por: Thakkar, Sampark S., et al.
Publicado: (2021)

Multiple sites on SARS‐CoV‐2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V
por: Bollavaram, Keval, et al.
Publicado: (2021)

Effect of different human tissue processing techniques on SARS-CoV-2 inactivation-review
por: Paggiaro, André Oliveira, et al.
Publicado: (2020)

Corticosteroid therapy is associated with the delay of SARS-CoV-2 clearance in COVID-19 patients
por: Huang, Rui, et al.
Publicado: (2020)

Crystal structure of Nsp15 endoribonuclease NendoU from SARS‐CoV‐2
por: Kim, Youngchang, et al.
Publicado: (2020)

Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury
por: Lin, Yong, et al.
Publicado: (2020)

Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection
por: Dehgani-Mobaraki, Puya, et al.
Publicado: (2021)

Insights into the conformation changes of SARS-CoV-2 spike receptor-binding domain on graphene
por: Du, Jianbin, et al.
Publicado: (2022)

A peptide-based assay discriminates individual antibody response to SARS-CoV-2
por: Polvere, Immacolata, et al.
Publicado: (2021)

Host and viral proteins involved in SARS‐CoV‐2 infection differentially bind heme
por: Hopp, Marie‐T., et al.
Publicado: (2022)

Wastewater-based epidemiological investigation of SARS-CoV-2 in Porto Alegre, Southern Brazil
por: Aschidamini Prandi, Bruno, et al.
Publicado: (2022)

Evolutionary trajectory of receptor binding specificity and promiscuity of the spike protein of SARS‐CoV‐2
por: Planchais, Cyril, et al.
Publicado: (2022)

Changes in buprenorphine visits in frontier and remote locations: Effects of the SARS-CoV-2 pandemic
por: McFadden, Lisa M.
Publicado: (2023)

Changes in haemostasis and inflammatory markers after mRNA BNT162b2 and vector Ad26.CoV2.S SARS-CoV-2 vaccination
por: Ivanko, I., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kdajh24lhfl0ckm9qfeiefah1d